Iurlo, Alessandra |
| Active, not recruiting | 3 | 430 | Europe, Canada, US, RoW | Pelabresib, Ruxolitinib, Placebo | Constellation Pharmaceuticals | Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis | 08/23 | 12/27 | | |
|
|
|
|
OPTKIMA, NCT02326311: Optimization of TKIs Treatment and Quality of Life in Ph+ CML Patients ≥60 Years in Deep Molecular Response |
|
|
| Recruiting | 3 | 502 | Europe | imatinib, Glivec, nilotinib, Tasigna, dasatinib, Sprycell | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Leukemia, Chronic Myeloid | 12/23 | 12/23 | | |
| Not yet recruiting | 2 | 50 | Europe | Ponatinib 15mg QD, ICLUSIG, AP24534, Ponatinib 30mg QD | Associazione Italiana Pazienti Leucemia Mieloide Cronica | Chronic Myeloid Leukemia (CML) | 10/24 | 04/25 | | |
NCT02629692 / 2016-001754-18: Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies |
|
|
| Active, not recruiting | 1/2 | 122 | Europe, US, RoW | Vodobatinib (K0706) capsules | Sun Pharma Advanced Research Company Limited | Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C) | 08/26 | 08/26 | | |
TFR-PRO, NCT04621851: Retro-prospective Observational Study on Risk of Progression in CP-CML Patients Eligible for TKI Discontinuation |
|
|
| Recruiting | N/A | 3000 | Europe, Canada | | University of Milano Bicocca | Chronic Myeloid Leukemia | 09/21 | 09/23 | | |
| Recruiting | N/A | 552 | Europe, US, RoW | | Fondazione per la Ricerca Ospedale Maggiore, European Leukemia Net | Myeloproliferative Neoplasm, COVID | 02/22 | 08/22 | | |
CML1012, NCT01752062: Observational Study of Conception/Pregnancy in Adult Patients With CML Treated With Tyrosine Kinase Inhibitors |
|
|
| Recruiting | N/A | 148 | Europe | | Gruppo Italiano Malattie EMatologiche dell'Adulto | Chronic Myeloid Leukemia, Pregnancy | 12/22 | 12/22 | | |
| Recruiting | N/A | 100 | Europe | Therapeutic drug monitoring, Molecular Response | University of Pisa | Chronic Myeloid Leukemia, Chronic Phase | 01/24 | 12/24 | | |